Aster DM Healthcare intimated stock exchanges of an upcoming board meeting on April 30, 2026.
The board will consider and approve audited standalone and consolidated financial results for Q4 and FY ending March 31, 2026.
The disclosure is made pursuant to Regulation 29 of SEBI LODR Regulations, 2015.
The company secretary and compliance officer, Hemish Purushottam, signed the intimation.